Ulthera Press Releases

Merz Finalizes Acquisition of Medical Device Company Ulthera, Inc.

Company’s Largest Acquisition Strengthens Aesthetics Business

July 29, 2014

  Merz and Ulthera, Inc. have finalized a transaction for Merz to acquire the global medical device company, officials announced today. This announcement follows the necessary regulatory review by the U.S. Federal Trade Commission and the U.S. Department of Justice. The addition of Ulthera’s energy device technology complements Merz’s current offerings and expands the specialty pharmaceutical company‘s aesthetics portfolio. MORE | PDF

Ultherapy® Décolletage Treatment Now FDA-Cleared

First Non-invasive Procedure Specifically Indicated by the FDA to Improve Lines and Wrinkles on the Décolleté

July 7, 2014

  Ulthera, Inc., a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications, announced today that its ultrasound platform device, the Ulthera® System, has received FDA clearance to non-invasively treat the chest to improve lines and wrinkles of the décolleté. MORE | PDF

Merz to Acquire Ulthera, Inc., a Leading Energy Device Company in the Area of Non-surgical Lift

June 26, 2014

  Merz and Ulthera, Inc. today announced that they have entered a definitive merger agreement, pursuant to which Merz will acquire global medical device company Ulthera, a deal which will accelerate Merz’s growth in the aesthetics area and expand the company’s portfolio of treatment options in facial aesthetics. MORE | PDF

Ulthera, Inc. Appoints Marshall L. Mohr to Board of Directors

April 10, 2014

  Ulthera, Inc., a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications, announced today that Marshall L. Mohr has joined its board of directors. MORE | PDF

Ulthera, Inc. Plans to Enter Cellulite Market with Acquisition of Cabochon Aesthetics, Inc.

Clinically proven procedure improves the appearance of cellulite

March 21, 2014

  Ulthera, Inc., a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications, announced today that it has acquired Cabochon Aesthetics, Inc. (Cabochon), the ninth company started by premier medical device incubator, The Foundry. The FDA-cleared system developed by Cabochon – used in a procedure to improve the appearance of cellulite – will allow Ulthera to expand its technology offerings for physician practices worldwide. MORE | PDF

Ulthera® System Receives Third FDA Clearance

Non-invasive Ultherapy® ultrasound procedure recognized for imaging capabilities

January 30, 2014

  Ulthera, Inc. – a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications – announced today that its ultrasound platform device, the Ulthera System, has been cleared by the Food and Drug Administration (FDA) to visualize the dermal and subdermal layers of tissue during the non-invasive lifting treatment, Ultherapy. MORE | PDF

Ultherapy® Named “Best In-Office Treatment” in NewBeauty’s Annual Beauty Choice Awards

January 22, 2014

  Ulthera, Inc. – a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications – announced today that its signature non-invasive lifting treatment, Ultherapy, was named “Best In-Office Treatment” in NewBeauty’s 2013 Beauty Choice Awards. MORE | PDF

Ultherapy® Clinical Studies to be Presented at AACS 2014 Annual Scientific Meeting Symposia

January 14, 2014

  Ulthera, Inc. announced today that its platform ultrasound technology, the Ulthera® System, will be featured in three symposia at the American Academy of Cosmetic Surgery (AACS) 30th Annual Scientific Meeting, Jan. 14-19, 2014 in Hollywood, Fla. at The Westin Diplomat Resort & Spa. Ulthera, Inc. is a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications. MORE | PDF

Ulthera’s Gregory Waller Named a Most Outstanding CFO by Phoenix Business Journal

December 16, 2013

  Ulthera, Inc. – a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications – today announced that its Chief Financial Officer, Gregory Waller, was recognized as one of Phoenix’s “Most Outstanding CFOs” of 2013 by the Phoenix Business Journal. MORE | PDF

Ultherapy Procedure Now Available in Taiwan for Non-Invasive Brow Lift

December 9, 2013

  Ulthera, Inc. – A global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications – today announced that it is now registered in Taiwan to market and distribute its patented medical device, the Ulthera System. The System – which combines established ultrasound imaging with focused ultrasound therapy in a treatment known as Ultherapy – is cleared in Taiwan as a non-invasive therapy used for eyebrow lift. MORE | PDF

Ulthera to Present at 25th Annual Piper Jaffray Healthcare Conference

December 2, 2013

  Ulthera, Inc. – a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications – today announced it will be participating in the 25th Annual Piper Jaffray Healthcare Conference in New York on Dec. 3-4, 2013. MORE | PDF

Ulthera to Present at Canaccord Genuity Medical Technology & Diagnostics Forum

November 13, 2013

  Ulthera, Inc. – a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications – today announced it will be participating in the 2013 Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 14 at The Westin New York Grand Central in New York, NY.

Ulthera’s presentation is scheduled for Thursday, November 14, 2013 at 2:00 pm EST. MORE | PDF

Ulthera Launches System Upgrade to Bring Amplified Value to Customers

Ultherapy Amplify software upgrade integrates enhancements for its cosmetic lifting procedure to increase patient comfort and procedure efficiency as well as to optimize treatment outcomes

October 16, 2012

  Ulthera, Inc. –a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today unveiled its new Ulthera® System software upgrade, Ultherapy Amplify, which is now commercially available in the U.S. in new Systems and is currently being rolled out to existing Ulthera customers at no charge. MORE | PDF

Ulthera Announces Issuance of Patent for New Medical Field of Use

Patent for non-invasive sweat reduction treatment expands intellectual property portfolio for the Ulthera System platform

October 12, 2012

  Ulthera, Inc. – a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – announces the issuance of U.S. Patent No. 8,282,554 this week from the U.S. Patent and Trademark Office (USPTO). The patent, titled “Methods for Treatment of Sweat Glands” relates to the therapeutic use of energy for the treatment of conditions resulting from sweat gland disorders, such as hyperhidrosis. MORE | PDF

Ulthera Receives First-Ever FDA Clearance for Non-invasive Lift of Skin on the Neck and Under the Chin

October 10, 2012

  Ulthera, Inc. – a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced that its ultrasound platform device, the Ulthera System, has received FDA clearance to non-invasively lift lax tissue on the neck and the submental (under the chin). MORE | PDF

Ulthera Receives Clearance to Market Ultrasound Platform Device in Brazil

Ultherapy Procedure Now Available in the Second-Largest Worldwide Market for Aesthetic Treatments

August 16, 2012

  Ulthera, Inc. – a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced that it is now registered in Brazil to market and distribute its patented medical device, the Ulthera System. The System – which combines time-honored ultrasound imaging with focused ultrasound therapy in a treatment known as Ultherapy – is cleared in the country to treat the face to encourage the natural formation of collagen and elastin in the skin, giving it the ability to lift tissue. MORE | PDF

Increased Market Demand for Ulthera’s Ultrasound Platform Technology Fuels Installation of 1,000th System Worldwide

An estimated 100,000 non-surgical Ultherapy procedures performed to lift and tighten skin

July 25, 2012

  Ulthera, Inc. – a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced that more than 1,000 Ulthera Systems have been sold globally while treatments performed using the System have surpassed 100,000. MORE | PDF

Ulthera Launches New Aesthetic Clinical Indication – Treatment of the Décolletage – in Asia

Non-invasive ultrasound procedure, Ultherapy, to now lift and tighten skin on the chest

July 3, 2012

  Ulthera, Inc. – a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced the commercial availability of the Ulthera System in select Asian countries to non-invasively treat the skin on the chest area – also known as the décolletage or décolleté. MORE | PDF

Ulthera Receives Clearance to Market Ultrasound Platform Device in Mexico

Arfamex to distribute the Ulthera System for cosmetic tissue lifting

March 16, 2012

  Ulthera, Inc. – a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced that it is now registered in Mexico to market and distribute its patented medical device, the Ulthera System. MORE | PDF

Ulthera To Expand Operations

New Manufacturing Facility and Continued Operational Growth Anticipated to Create More Than 100 New Jobs in Mesa

February 10, 2012

  Ulthera, Inc. – a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – will expand its operations to now include the manufacturing of various components of its patented technology. This expansion as well as continued product development and operational growth are anticipated to create more than 100 new, high- wage jobs and result in $1.68 million of capital investment by 2014. MORE | PDF

Ulthera Appoints Greg Waller as Chief Financial Officer

Financial executive brings 35 years of global, high-growth experience

December 6, 2011

  Ulthera, Inc. — a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology — today announced that it has named Greg Waller as Chief Financial Officer (CFO), a newly created position at Ulthera. MORE | PDF

Ulthera CEO - Matthew Likens - to Present at Two Upcoming Healthcare Conferences

23rd Annual Piper Jaffray Healthcare Conference; 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference

November 22, 2011

  Matthew Likens, president and CEO of Ulthera, Inc. — a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology — is scheduled to present at two upcoming healthcare conferences. MORE | PDF

Ulthera Announces $10.5 Million in Series C Venture Capital Funding

February 8, 2011

  Ulthera, Inc., developer of the Ulthera® System, the first-ever ultrasound device approved by the FDA for aesthetics, announced today the recent completion of $10.5 million in Series C venture funding. The funding was led by New Enterprise Associates (NEA) with participation by funds managed by Apposite Capital LLP. MORE | PDF

Ulthera® Receives First-Ever FDA Clearance to Market Ultrasound Technology for Facial Aesthetic Improvement

New DeepSEE™ Ultrasound for Non-Invasive Lift

September 16, 2009

  Ulthera, Inc., a therapeutic ultrasound medical device company serving the $30 billion global aesthetics market, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the use of its Ulthera™ System to achieve a non-invasive eyebrow lift. MORE | PDF

Ulthera® Receives Health Canada Clearance to Market Ultrasound Technology for Facial Aesthetic Improvement

May 26, 2009

  Ulthera, Inc. today announced that it has received a Health Canada license for use of its Ulthera™ System in lifting and tightening lax skin. MORE | PDF

Ulthera® Receives $22.5 Million in Series B Round

Funds support company's commercialization and product development initiatives

January 17, 2008

  Ulthera, Inc., a therapeutic ultrasound medical device company serving the aesthetics market, today announced that it has received $22.5 million in a Series B round that was led by New Enterprise Associates (NEA). Existing investor 3i also participated in the round. MORE | PDF

Contact Media Relations

Ulthera, Inc.

2150 S. Country Club Drive, Suite 21
Mesa, AZ 85210
(480) 619-4069 ext. 144
pr@ulthera.com




In the News

Harper's Bazaar

November 2013
See all our media coverage >